The PE Ratio as of September 2024 (TTM) for Sirona Biochem Corp. (SRBCF) is -4.51

According to Sirona Biochem Corp.’s latest financial reports and current stock price. The company's current PE Ratio is -4.51. This represents a change of -53.95% compared to the average of -9.79 of the last 4 quarters.

Sirona Biochem Corp. (SRBCF) Historical PE Ratio (quarterly & annually)

How has SRBCF PE Ratio performed in the past?

The mean historical PE Ratio of Sirona Biochem Corp. over the last ten years is -10.73. The current -4.51 PE Ratio has changed 4.10% with respect to the historical average. Over the past ten years (40 quarters), SRBCF's PE Ratio was at its highest in in the July 2018 quarter at 38.03. The PE Ratio was at its lowest in in the January 2018 quarter at -50.01.

Sirona Biochem Corp. (SRBCF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Sirona Biochem Corp. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Sirona Biochem Corp. (SRBCF) Average PE Ratio

How has SRBCF PE Ratio performed in the past?

The current PE Ratio of Sirona Biochem Corp. (SRBCF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Sirona Biochem Corp. (SRBCF) PE Ratio vs. Peers

How is SRBCF’s PE Ratio compared to its peers?

Sirona Biochem Corp.’s PE Ratio is less than Adynxx, Inc. (0), less than NLS Pharmaceutics AG (0), less than Ascletis Pharma Inc. (-0.36), greater than Surrozen, Inc. (-55.69), less than Bolt Biotherapeutics, Inc. (-0.47), less than Larimar Therapeutics, Inc. (-0.36), greater than Keros Therapeutics, Inc. (-7.49), greater than Kezar Life Sciences, Inc. (-11.97), less than Coya Therapeutics, Inc. (-0.43), greater than Cue Biopharma, Inc. (-8.95), less than Lantern Pharma Inc. (-0.59), less than Fennec Pharmaceuticals Inc. (-2.37), less than Eliem Therapeutics, Inc. (53.53), less than SciSparc Ltd. (-3.77), less than OncoSec Medical Incorporated (-0.02), less than Virax Biolabs Group Limited (-0.05), less than Hillstream BioPharma, Inc. (-1.03), less than ZyVersa Therapeutics, Inc. (-0.00), less than Eiger BioPharmaceuticals, Inc. (-0.09), less than Spruce Biosciences, Inc. (-0.03), less than Werewolf Therapeutics, Inc. (-0.43), less than Unicycive Therapeutics, Inc. (-1.80), less than Fusion Pharmaceuticals Inc. (-0.51), greater than null (-17.31),

Build a custom stock screener for Sirona Biochem Corp. (SRBCF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sirona Biochem Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sirona Biochem Corp. (SRBCF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sirona Biochem Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.